Metabolic Syndrome

Is Placebo Still Ethical in Trials of Incretin Therapies? Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit SARM1 Regulates BNIP3-Mediated Mitochondrial Quality Control in Diabetic Hearts Hypertension in Overweight and Obesity: Sex‐Specific Role of 4β‐Hydroxycholesterol Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae 2026 Heart Disease and Stroke Statistics Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis